We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
257 hedge funds and large institutions have $6.41B invested in Madrigal Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 111 increasing their positions, 64 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
73% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 64
68% more call options, than puts
Call options by funds: $312M | Put options by funds: $186M
14% more capital invested
Capital invested by funds: $5.64B → $6.41B (+$771M)
1.25% more ownership
Funds ownership: 106.08% → 107.33% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
4% less funds holding
Funds holding: 268 → 257 (-11)
11% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 55
Holders
257
Holders Change
-11
Holders Change %
-4.1%
% of All Funds
3.71%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
49
Increased
111
Reduced
64
Closed
55
Calls
$312M
Puts
$186M
Net Calls
+$126M
Net Calls Change
+$131M
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$362M |
| 2 |
BlackRock
New York
|
+$51.6M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$36.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$30.1M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$54.6M |
| 2 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$52.6M |
| 3 |
PA
Perceptive Advisors
New York
|
-$39.4M |
| 4 |
AG
Artal Group
Luxembourg
|
-$29.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$27.5M |
